Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Definition

2. Executive Summary

3. Impact of COVID-19 on Global Tissue Imaging Market

4. Global Tissue Imaging Market Trends & Insights

5. Global Tissue Imaging Market Dynamics
5.1. Drivers
5.2. Challenges
5.3. Impact Analysis

6. Global Tissue Imaging Market Hotspots & Opportunities

7. Global Tissue Imaging Market Supply & Demand Analysis

8. Global Tissue Imaging Market Regulations & Policy
8.1. By Region
8.1.1. North America
8.1.1.1. The US
8.1.2. Europe
8.1.3. Asia Pacific
8.1.3.1. Japan
8.1.3.2. China
8.1.3.3. India
8.1.4. Middle East & Africa

9. Global Tissue Imaging Market Patent Analysis

10. List of Associations/Consortiums/Regulatory Bodies (with Establishment Year, and Region)

11. Global Tissue Imaging Market Outlook, 2016-2026F
11.1. Market Size & Analysis
11.1.1. By Revenues
11.2. Market Share & Analysis
11.2.1. By Technology
11.2.1.1. Mass Spectroscopy
11.2.1.1.1. MALDI Imaging
11.2.1.1.2. DESI Imaging
11.2.1.1.3. SIMS Imaging
11.2.1.2. Immunohistochemistry (IHC)
11.2.1.3. Flow Cytometry
11.2.1.4. Digital Pathology
11.2.1.5. In Situ Hybridization (ISH)
11.2.1.5.1. Fluorescence In-Situ Hybridization (FISH)
11.2.1.5.1.1. DNA Fluorescence In-Situ Hybridization
11.2.1.5.1.2. RNA Fluorescence In-Situ Hybridization
11.2.1.5.1.3. Protein Fluorescence In-Situ Hybridization
11.2.1.5.2. Chromogenic In-Situ Hybridization (CISH)
11.2.1.6. Immunofluorescence
11.2.1.6.1. Indirect Immunofluorescence (Secondary)
11.2.1.6.2. Direct Immunofluorescence (Primary)
11.2.2. By Product
11.2.2.1. Platforms
11.2.2.1.1. Mass Spectroscopy Imaging (MSI) platforms
11.2.2.1.2. Flow Cytometry Analyzers
11.2.2.1.3. Digital Pathology Scanners
11.2.2.1.4. Immunohistochemistry Detection Systems
11.2.2.1.5. In-Situ Hybridization Platforms
11.2.2.1.6. Immunofluorescence Imaging Analysis Systems
11.2.2.1.7. Tissue Microarray Platforms
11.2.2.2. Microscopes
11.2.2.2.1. Optical Microscopes
11.2.2.2.1.1. Compound Microscopes
11.2.2.2.1.2. Digital Microscopes
11.2.2.2.1.3. Fluorescence Microscopes
11.2.2.2.1.4. Others
11.2.2.2.2. Electron Microscopes
11.2.2.2.2.1. Scanning Electron Microscopes (SEM)
11.2.2.2.2.2. Transmission Electron Microscopes (TEM)
11.2.2.2.3. Scanning Probe Microscopes
11.2.2.2.4. Others
11.2.2.3. Consumables
11.2.2.3.1. Antibodies & Reagents
11.2.2.3.2. Kits
11.2.2.3.3. Probes
11.2.2.3.4. Others
11.2.2.4. Software
11.2.2.5. Accessories
11.2.3. By Therapeutic Application
11.2.3.1. By Disease Research
11.2.3.1.1. Oncology Research
11.2.3.1.2. Infectious Diseases Research
11.2.3.1.3. Neurological Disease Research
11.2.3.1.4. Cardiovascular Disease Research
11.2.3.1.5. Immunological Disease Research
11.2.3.1.6. Other Diseases Research
11.2.3.2. By Diagnostics
11.2.3.2.1. Oncology Diagnostics
11.2.3.2.2. Infectious Diseases Diagnostics
11.2.3.2.3. Neurological Disease Diagnostics
11.2.3.2.4. Cardiovascular Disease Diagnostics
11.2.3.2.5. Immunological Disease Diagnostics
11.2.3.2.6. Others Diseases Diagnostics
11.2.4. By End User
11.2.4.1. Biotechnology Companies
11.2.4.2. Pharmaceutical Companies
11.2.4.3. Contract Research Organizations (CROs)
11.2.4.4. Academic and Research Institutions
11.2.4.5. Hospitals and Diagnostic Laboratories
11.2.5. By Region
11.2.5.1. North America
11.2.5.2. Latin America
11.2.5.3. Europe
11.2.5.4. Middle East & Africa
11.2.5.5. Asia-Pacific
11.2.6. By Competitors
11.2.6.1. Competition Characteristics
11.2.6.2. Market Share & Analysis
11.2.6.3. Competitive Matrix

12. North America Tissue Imaging Market Outlook, 2016-2026F
12.1. Market Size & Analysis
12.1.1. By Revenues
12.2. Market Share & Analysis
12.2.1. By Technology
12.2.2. By Product
12.2.3. By Therapeutic Application
12.2.4. By End User
12.2.5. By Country
12.2.5.1. The U.S.
12.2.5.2. Canada
12.3. The U.S. Tissue Imaging Market Outlook, 2016-2026F
12.3.1. Market Size & Analysis
12.3.1.1. By Revenues
12.3.2. Market Share & Analysis
12.3.2.1. By Technology
12.3.2.2. By Product
12.3.2.3. By Therapeutic Application
12.3.2.4. By End User
12.4. Canada Tissue Imaging Market Outlook, 2016-2026F
12.4.1. Market Size & Analysis
12.4.1.1. By Revenues
12.4.2. Market Share & Analysis
12.4.2.1. By Technology
12.4.2.2. By Product
12.4.2.3. By Therapeutic Application
12.4.2.4. By End User

13. Latin America Tissue Imaging Market Outlook, 2016-2026F
13.1. Market Size & Analysis
13.1.1. By Revenues
13.2. Market Share & Analysis
13.2.1. By Technology
13.2.2. By Product
13.2.3. By Therapeutic Application
13.2.4. By End User
13.2.5. By Country
13.2.5.1. Brazil
13.2.5.2. Mexico
13.3. Brazil Tissue Imaging Market Outlook, 2016-2026F
13.3.1. Market Size & Analysis
13.3.1.1. By Revenues
13.3.2. Market Share & Analysis
13.3.2.1. By Technology
13.3.2.2. By Product
13.3.2.3. By Therapeutic Application
13.3.2.4. By End User
13.4. Mexico Tissue Imaging Market Outlook, 2016-2026F
13.4.1. Market Size & Analysis
13.4.1.1. By Revenues
13.4.2. Market Share & Analysis
13.4.2.1. By Technology
13.4.2.2. By Product
13.4.2.3. By Therapeutic Application
13.4.2.4. By End User

14. Europe Tissue Imaging Market Outlook, 2016-2026F
14.1. Market Size & Analysis
14.1.1. By Revenues
14.2. Market Share & Analysis
14.2.1. By Technology
14.2.2. By Product
14.2.3. By Therapeutic Application
14.2.4. By End User
14.2.5. By Country
14.2.5.1. The U.K.
14.2.5.2. Germany
14.2.5.3. France
14.2.5.4. Rest of Europe
14.3. The U.K. Tissue Imaging Market Outlook, 2016-2026F
14.3.1. Market Size & Analysis
14.3.1.1. By Revenues
14.3.2. Market Share & Analysis
14.3.2.1. By Technology
14.3.2.2. By Product
14.3.2.3. By Therapeutic Application
14.3.2.4. By End User
14.4. Germany Tissue Imaging Market Outlook, 2016-2026F
14.4.1. Market Size & Analysis
14.4.1.1. By Revenues
14.4.2. Market Share & Analysis
14.4.2.1. By Technology
14.4.2.2. By Product
14.4.2.3. By Therapeutic Application
14.4.2.4. By End User
14.5. France Tissue Imaging Market Outlook, 2016-2026F
14.5.1. Market Size & Analysis
14.5.1.1. By Revenues
14.5.2. Market Share & Analysis
14.5.2.1. By Technology
14.5.2.2. By Product
14.5.2.3. By Therapeutic Application
14.5.2.4. By End User
14.6. Rest of Europe Tissue Imaging Market Outlook, 2016-2026F
14.6.1. Market Size & Analysis
14.6.1.1. By Revenues
14.6.2. Market Share & Analysis
14.6.2.1. By Technology
14.6.2.2. By Product
14.6.2.3. By Therapeutic Application
14.6.2.4. By End User
15. Middle East & Africa (MEA) Tissue Imaging Market Outlook, 2016-2026F
15.1. Market Size & Analysis
15.1.1. By Revenues
15.2. Market Share & Analysis
15.2.1. By Technology
15.2.2. By Product
15.2.3. By Therapeutic Application
15.2.4. By End User
15.2.5. By Country
15.2.5.1. UAE
15.2.5.2. Saudi Arabia
15.2.5.3. South Africa
15.2.5.4. Rest of MEA
15.3. UAE Tissue Imaging Market Outlook, 2016-2026F
15.3.1. Market Size & Analysis
15.3.1.1. By Revenues
15.3.2. Market Share & Analysis
15.3.2.1. By Technology
15.3.2.2. By Product
15.3.2.3. By Therapeutic Application
15.3.2.4. By End User
15.4. Saudi Arabia Tissue Imaging Market Outlook, 2016-2026F
15.4.1. Market Size & Analysis
15.4.1.1. By Revenues
15.4.2. Market Share & Analysis
15.4.2.1. By Technology
15.4.2.2. By Product
15.4.2.3. By Therapeutic Application
15.4.2.4. By End User
15.5. South Africa Tissue Imaging Market Outlook, 2016-2026F
15.5.1. Market Size & Analysis
15.5.1.1. By Revenues
15.5.2. Market Share & Analysis
15.5.2.1. By Technology
15.5.2.2. By Product
15.5.2.3. By Therapeutic Application
15.5.2.4. By End User
15.6. Rest of Middle East & Africa (MEA) Tissue Imaging Market Outlook, 2016-2026F
15.6.1. Market Size & Analysis
15.6.1.1. By Revenues
15.6.2. Market Share & Analysis
15.6.2.1. By Technology
15.6.2.2. By Product
15.6.2.3. By Therapeutic Application
15.6.2.4. By End User
16. Asia-Pacific Tissue Imaging Market Outlook, 2016-2026F
16.1. Market Size & Analysis
16.1.1. By Revenues
16.2. Market Share & Analysis
16.2.1. By Technology
16.2.2. By Product
16.2.3. By Therapeutic Application
16.2.4. By End User
16.2.5. By Country
16.2.5.1. China
16.2.5.2. India
16.2.5.3. Japan
16.2.5.4. South Korea
16.2.5.5. Australia
16.2.5.6. Rest of Asia-Pacific
16.3. India Tissue Imaging Market Outlook, 2016-2026F
16.3.1. Market Size & Analysis
16.3.1.1. By Revenues
16.3.2. Market Share & Analysis
16.3.2.1. By Technology
16.3.2.2. By Product
16.3.2.3. By Therapeutic Application
16.3.2.4. By End User
16.4. China Tissue Imaging Market Outlook, 2016-2026F
16.4.1. Market Size & Analysis
16.4.1.1. By Revenues
16.4.2. Market Share & Analysis
16.4.2.1. By Technology
16.4.2.2. By Product
16.4.2.3. By Therapeutic Application
16.4.2.4. By End User
16.5. Japan Tissue Imaging Market Outlook, 2016-2026F
16.5.1. Market Size & Analysis
16.5.1.1. By Revenues
16.5.2. Market Share & Analysis
16.5.2.1. By Technology
16.5.2.2. By Product
16.5.2.3. By Therapeutic Application
16.5.2.4. By End User
16.6. South Korea Tissue Imaging Market Outlook, 2016-2026F
16.6.1. Market Size & Analysis
16.6.1.1. By Revenues
16.6.2. Market Share & Analysis
16.6.2.1. By Technology
16.6.2.2. By Product
16.6.2.3. By Therapeutic Application
16.6.2.4. By End User
16.7. Australia Tissue Imaging Market Outlook, 2016-2026F
16.7.1. Market Size & Analysis
16.7.1.1. By Revenues
16.7.2. Market Share & Analysis
16.7.2.1. By Technology
16.7.2.2. By Product
16.7.2.3. By Therapeutic Application
16.7.2.4. By End User
16.8. Rest of Asia-Pacific Tissue Imaging Market Outlook, 2016-2026F
16.8.1. Market Size & Analysis
16.8.1.1. By Revenues
16.8.2. Market Share & Analysis
16.8.2.1. By Technology
16.8.2.2. By Product
16.8.2.3. By Therapeutic Application
16.8.2.4. By End User

17. Key Strategic Imperatives for Success and Growth

18. Competition Outlook
18.1. Competition Matrix
18.1.1. Brand Specialization
18.1.2. Target Markets
18.1.3. Target End Users
18.1.4. Research & Development
18.1.5. Strategic Alliances
18.1.6. Strategic Initiatives
18.2. Company Profiles
18.2.1. Abbott Laboratories
18.2.2. Roche Holding AG
18.2.3. Bio-Rad Laboratories, Inc.
18.2.4. Bio SB
18.2.5. Agilent Technologies
18.2.6. Olympus Corporation
18.2.7. Abcam Plc
18.2.8. Biocare Medical LLC
18.2.9. Sakura Finetek
18.2.10. LifeSpan BioSciences, Inc.
18.2.11. Hamamatsu Photonics K.K.
18.2.12. Fluidigm Corporation
18.2.13. Danaher Corporation
18.2.14. Merck KGaA
18.2.15. Thermo Fisher Scientific Inc.
18.2.16. Becton, Dickinson and Company
18.2.17. F. Hoffmann-La Roche Ltd
18.2.18. Vector Laboratories
18.2.19. Shimadzu Corporation
18.2.20. Nikon Corporation
18.2.21. PerkinElmer Inc.

19. Disclaimer